Tang Capital Management LLC Altimmune, Inc. Call Options Transaction History
Tang Capital Management LLC
- $1.67 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALT
# of Institutions
214Shares Held
36.1MCall Options Held
4.92MPut Options Held
4.18M-
Black Rock Inc. New York, NY5.32MShares$21.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$20.6 Million0.0% of portfolio
-
State Street Corp Boston, MA2.75MShares$11 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.93MShares$7.7 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.62MShares$6.45 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $195M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...